Chemoinformaics analysis of 1-cafeoylquinic acids
| Molecular Weight | 354.311 | nRot | 4 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 15 |
| Exact Molecular Weight | 354.095 | nRing | 2 |
| Solubility: LogS | -1.002 | nHRing | 0 |
| Solubility: LogP | -0.153 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 45.9403 |
| nHD | 6 | BPOL | 21.5297 |
| QED | 0.234 |
| Synth | 3.635 |
| Natural Product Likeliness | 1.902 |
| NR-PPAR-gamma | 0.745 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.757 |
| HIA | 0.908 |
| CACO-2 | -6.117 |
| MDCK | 0.000309756 |
| BBB | 0.647 |
| PPB | 0.559512 |
| VDSS | 0.401 |
| FU | 0.482186 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.124 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.025 |
| CL | 2.087 |
| T12 | 0.927 |
| hERG | 0.009 |
| Ames | 0.044 |
| ROA | 0.024 |
| SkinSen | 0.241 |
| Carcinogencity | 0.05 |
| EI | 0.036 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.73675 |